Long‐term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial
Sonali Chaudhury(Northwestern University), Joel Brochstein, Kimberly A. Kasow(University of North Carolina at Chapel Hill), Naynesh Kamani(American Association of Blood Banks), Mark C. Walters(UCSF Benioff Children's Hospital), Mary Eapen(Medical College of Wisconsin), John E. Levine(Icahn School of Medicine at Mount Sinai), Lakshmanan Krishnamurti(Emory University), Martin Andreánsky(University of Miami Health System), Jianqun Kou(Georgia State University), Mary M. Horowitz(Medical College of Wisconsin), Shalini Shenoy, David Jacobsohn, Monica Bhatia, Lolie C. Yu, David Margolis, Jennifer Jaroscak, Hilary Haines(Children's of Alabama), Ann E. Haight, Kathryn Leung(Emory University)
Cited by 0
Related Papers
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
|Journal of Clinical Oncology|2001|682